These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 27355626)

  • 21. Temporal Trends in HIV-1 Mutations Used for the Surveillance of Transmitted Drug Resistance.
    Rhee SY; Tzou PL; Shafer RW
    Viruses; 2021 May; 13(5):. PubMed ID: 34064774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low prevalence of transmitted drug resistance of HIV-1 during 2008-2012 antiretroviral therapy scaling up in Southern Vietnam.
    Tanuma J; Quang VM; Hachiya A; Joya A; Watanabe K; Gatanaga H; Van Vinh Chau N; Chinh NT; Oka S
    J Acquir Immune Defic Syndr; 2014 Aug; 66(4):358-64. PubMed ID: 24815852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe.
    Hofstra LM; Sauvageot N; Albert J; Alexiev I; Garcia F; Struck D; Van de Vijver DAMC; Åsjö B; Beshkov D; Coughlan S; Descamps D; Griskevicius A; Hamouda O; Horban A; Van Kasteren M; Kolupajeva T; Kostrikis LG; Liitsola K; Linka M; Mor O; Nielsen C; Otelea D; Paraskevis D; Paredes R; Poljak M; Puchhammer-Stöckl E; Sönnerborg A; Staneková D; Stanojevic M; Van Laethem K; Zazzi M; Zidovec Lepej S; Boucher CAB; Schmit JC; Wensing AMJ; ; Puchhammer-Stockl E; Sarcletti M; Schmied B; Geit M; Balluch G; Vandamme AM; Vercauteren J; Derdelinckx I; Sasse A; Bogaert M; Ceunen H; De Roo A; De Wit S; Echahidi F; Fransen K; Goffard JC; Goubau P; Goudeseune E; Yombi JC; Lacor P; Liesnard C; Moutschen M; Pierard D; Rens R; Schrooten Y; Vaira D; Vandekerckhove LPR; Van den Heuvel A; Van Der Gucht B; Van Ranst M; Van Wijngaerden E; Vandercam B; Vekemans M; Verhofstede C; Clumeck N; Van Laethem K; Beshkov D; Alexiev I; Lepej SZ; Begovac J; Kostrikis L; Demetriades I; Kousiappa I; Demetriou V; Hezka J; Linka M; Maly M; Machala L; Nielsen C; Jørgensen LB; Gerstoft J; Mathiesen L; Pedersen C; Nielsen H; Laursen A; Kvinesdal B; Liitsola K; Ristola M; Suni J; Sutinen J; Descamps D; Assoumou L; Castor G; Grude M; Flandre P; Storto A; Hamouda O; Kücherer C; Berg T; Braun P; Poggensee G; Däumer M; Eberle J; Heiken H; Kaiser R; Knechten H; Korn K; Müller H; Neifer S; Schmidt B; Walter H; Gunsenheimer-Bartmeyer B; Harrer T; Paraskevis D; Hatzakis A; Zavitsanou A; Vassilakis A; Lazanas M; Chini M; Lioni A; Sakka V; Kourkounti S; Paparizos V; Antoniadou A; Papadopoulos A; Poulakou G; Katsarolis I; Protopapas K; Chryssos G; Drimis S; Gargalianos P; Xylomenos G; Lourida G; Psichogiou M; Daikos GL; Sipsas NV; Kontos A; Gamaletsou MN; Koratzanis G; Sambatakou H; Mariolis H; Skoutelis A; Papastamopoulos V; Georgiou O; Panagopoulos P; Maltezos E; Coughlan S; De Gascun C; Byrne C; Duffy M; Bergin C; Reidy D; Farrell G; Lambert J; O'Connor E; Rochford A; Low J; Coakely P; O'Dea S; Hall W; Mor O; Levi I; Chemtob D; Grossman Z; Zazzi M; de Luca A; Balotta C; Riva C; Mussini C; Caramma I; Capetti A; Colombo MC; Rossi C; Prati F; Tramuto F; Vitale F; Ciccozzi M; Angarano G; Rezza G; Kolupajeva T; Vasins O; Griskevicius A; Lipnickiene V; Schmit JC; Struck D; Sauvageot N; Hemmer R; Arendt V; Michaux C; Staub T; Sequin-Devaux C; Wensing AMJ; Boucher CAB; van de Vijver DAMC; van Kessel A; van Bentum PHM; Brinkman K; Connell BJ; van der Ende ME; Hoepelman IM; van Kasteren M; Kuipers M; Langebeek N; Richter C; Santegoets RMWJ; Schrijnders-Gudde L; Schuurman R; van de Ven BJM; Åsjö B; Kran AB; Ormaasen V; Aavitsland P; Horban A; Stanczak JJ; Stanczak GP; Firlag-Burkacka E; Wiercinska-Drapalo A; Jablonowska E; Maolepsza E; Leszczyszyn-Pynka M; Szata W; Camacho R; Palma C; Borges F; Paixão T; Duque V; Araújo F; Otelea D; Paraschiv S; Tudor AM; Cernat R; Chiriac C; Dumitrescu F; Prisecariu LJ; Stanojevic M; Jevtovic D; Salemovic D; Stanekova D; Habekova M; Chabadová Z; Drobkova T; Bukovinova P; Shunnar A; Truska P; Poljak M; Lunar M; Babic D; Tomazic J; Vidmar L; Vovko T; Karner P; Garcia F; Paredes R; Monge S; Moreno S; Del Amo J; Asensi V; Sirvent JL; de Mendoza C; Delgado R; Gutiérrez F; Berenguer J; Garcia-Bujalance S; Stella N; de Los Santos I; Blanco JR; Dalmau D; Rivero M; Segura F; Elías MJP; Alvarez M; Chueca N; Rodríguez-Martín C; Vidal C; Palomares JC; Viciana I; Viciana P; Cordoba J; Aguilera A; Domingo P; Galindo MJ; Miralles C; Del Pozo MA; Ribera E; Iribarren JA; Ruiz L; de la Torre J; Vidal F; Clotet B; Albert J; Heidarian A; Aperia-Peipke K; Axelsson M; Mild M; Karlsson A; Sönnerborg A; Thalme A; Navér L; Bratt G; Karlsson A; Blaxhult A; Gisslén M; Svennerholm B; Bergbrant I; Björkman P; Säll C; Mellgren Å; Lindholm A; Kuylenstierna N; Montelius R; Azimi F; Johansson B; Carlsson M; Johansson E; Ljungberg B; Ekvall H; Strand A; Mäkitalo S; Öberg S; Holmblad P; Höfer M; Holmberg H; Josefson P; Ryding U
    Clin Infect Dis; 2016 Mar; 62(5):655-663. PubMed ID: 26620652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of HIV-1 transmitted drug resistance in recently infected, treatment-naïve persons in the Southwest of Iran, 2014-2015.
    Ghafari S; Memarnejadian A; Samarbaf-Zadeh A; Mostafavi E; Makvandi M; Salmanzadeh S; Ghadiri A; Jordan MR; Mousavi E; Jahanbakhsh F; Azadmanesh K
    Arch Virol; 2017 Sep; 162(9):2737-2745. PubMed ID: 28589513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trend of HIV-1 drug resistance in China: A systematic review and meta-analysis of data accumulated over 17 years (2001-2017).
    Zuo L; Liu K; Liu H; Hu Y; Zhang Z; Qin J; Xu Q; Peng K; Jin X; Wang JH; Zhang C
    EClinicalMedicine; 2020 Jan; 18():100238. PubMed ID: 31922125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of WHO transmitted drug resistance mutations by deep sequencing in antiretroviral-naïve subjects in Hunan Province, China.
    Xiaobai Z; Xi C; Tian H; Williams AB; Wang H; He J; Zhen J; Chiarella J; Blake LA; Turenchalk G; Kozal MJ
    PLoS One; 2014; 9(6):e98740. PubMed ID: 24896087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increase of transmitted drug resistance among HIV-infected sub-Saharan Africans residing in Spain in contrast to the native population.
    Yebra G; de Mulder M; Pérez-Elías MJ; Pérez-Molina JA; Galán JC; Llenas-García J; Moreno S; Holguín Á
    PLoS One; 2011; 6(10):e26757. PubMed ID: 22046345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV pretreatment drug resistance among cisgender MSM and transgender women from Lima, Peru.
    Trebelcock WL; Lama JR; Duerr A; Sanchez H; Cabello R; Gilada T; Segura P; Reisner SL; Mayer KH; Mullins J; Bender Ignacio RA
    J Int AIDS Soc; 2019 Nov; 22(11):e25411. PubMed ID: 31773888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequency and diversity of human immunodeficiency virus type 1 mutations associated with antiretroviral resistance among patients from Southern Brazil failing highly active antiretroviral therapy (HAART).
    Figueiredo Saad F; Kaminami Morimoto H; Wiechmann SL; Bonametti AM; Ueda LT; Matsuo T; Reiche EM
    Int J Mol Med; 2010 Oct; 26(4):585-93. PubMed ID: 20818500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug resistance in antiretroviral-naive children newly diagnosed with HIV-1 in Manaus, Amazonas.
    Andrade SD; Sabidó M; Monteiro WM; Benzaken AS; Tanuri A
    J Antimicrob Chemother; 2017 Jun; 72(6):1774-1783. PubMed ID: 28333295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brazilian network for HIV Drug Resistance Surveillance (HIV-BresNet): a survey of treatment-naive individuals.
    Arruda MB; Boullosa LT; Cardoso CC; da Costa CM; Alves CR; de Lima ST; Kaminski HT; Aleixo AW; Esposito AO; Cavalcanti AM; Riedel M; Couto-Fernandez JC; Ferreira SB; de Oliveira IC; Portal LE; Wolf HH; Fernandes SB; de M C Pardini MI; Feiteiro MV; Tolentino FM; Diaz RS; Lopes GI; Francisco RB; Véras NM; Pires AF; Franchini M; Mesquita F; Tanuri A;
    J Int AIDS Soc; 2018 Mar; 21(3):. PubMed ID: 29504269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV-1 drug resistance surveillance in antiretroviral treatment-naive individuals from a reference hospital in Guatemala, 2010-2013.
    Avila-Ríos S; García-Morales C; Garrido-Rodríguez D; Tapia-Trejo D; Girón-Callejas AC; Mendizábal-Burastero R; Escobar-Urias IY; García-González BL; Navas-Castillo S; Pinzón-Meza R; Mejía-Villatoro CR; Reyes-Terán G
    AIDS Res Hum Retroviruses; 2015 Apr; 31(4):401-11. PubMed ID: 25347163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessing the Paradox Between Transmitted and Acquired HIV Type 1 Drug Resistance Mutations in the Swiss HIV Cohort Study From 1998 to 2012.
    Yang WL; Kouyos R; Scherrer AU; Böni J; Shah C; Yerly S; Klimkait T; Aubert V; Furrer H; Battegay M; Cavassini M; Bernasconi E; Vernazza P; Held L; Ledergerber B; Günthard HF;
    J Infect Dis; 2015 Jul; 212(1):28-38. PubMed ID: 25576600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transmitted antiretroviral drug resistance in New York State, 2006-2008: results from a new surveillance system.
    Readhead AC; Gordon DE; Wang Z; Anderson BJ; Brousseau KS; Kouznetsova MA; Forgione LA; Smith LC; Torian LV
    PLoS One; 2012; 7(8):e40533. PubMed ID: 22879878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evolution of primary HIV drug resistance in a subtype C dominated epidemic in Mozambique.
    Bila DC; Young P; Merks H; Vubil AS; Mahomed M; Augusto A; Abreu CM; Mabunda NJ; Brooks JI; Tanuri A; Jani IV
    PLoS One; 2013; 8(7):e68213. PubMed ID: 23935858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of transmitted HIV-1 drug resistance among treatment-naive individuals in China, 2000-2016.
    Yuan H; Liu Z; Wu X; Wu M; Fang Q; Zhang X; Shi T; Tully DC; Zhang T
    Arch Virol; 2021 Sep; 166(9):2451-2460. PubMed ID: 34195923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surveillance of transmitted HIV-1 antiretroviral drug resistance in the context of decentralized HIV care in Senegal and the Ebola outbreak in Guinea.
    Mbange AE; Kaba D; Diouara AAM; Diop-Ndiaye H; Ngom-Ngueye NF; Dieng A; Lo S; Toure KN; Fall M; Mbacham WF; Diallo MS; Cisse M; Mboup S; Kane CT
    BMC Res Notes; 2018 Oct; 11(1):723. PubMed ID: 30309385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary drug resistance in South Africa: data from 10 years of surveys.
    Manasa J; Katzenstein D; Cassol S; Newell ML; de Oliveira T;
    AIDS Res Hum Retroviruses; 2012 Jun; 28(6):558-65. PubMed ID: 22251009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of transmitted HIV-1 drug resistance among young adults attending HIV counselling and testing clinics in Kigali, Rwanda.
    Mutagoma M; Ndahimana Jd; Kayirangwa E; Dahourou AG; Balisanga H; DeVos JR; McAlister D; Yang C; Bertagnolio S; Riedel DJ; Nsanzimana S
    Antivir Ther; 2016; 21(3):247-51. PubMed ID: 26458150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trend of HIV transmitted drug resistance before and after implementation of HAART regimen restriction in the treatment of HIV-1 infected patients in southern Taiwan.
    Weng YW; Chen IT; Tsai HC; Wu KS; Tseng YT; Sy CL; Chen JK; Lee SS; Chen YS
    BMC Infect Dis; 2019 Aug; 19(1):741. PubMed ID: 31443633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.